本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

98.73
+3.663.85%
成交量:9.80万
成交额:955.28万
市值:195.66亿
市盈率:-16.59
高:98.73
开:96.44
低:96.15
收:95.07
52周最高:124.49
52周最低:29.17
股本:1.98亿
流通股本:1.79亿
量比:1.31
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-5.9502
净资产收益率:-58.07%
总资产收益率:-30.08%
市净率:11.99
市盈率(LYR):-16.59

数据加载中...

2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities